On reassessment, the patient's urine culture demonstrated recurrent ciprofloxacin-resistant ESBL E
Linezolid is an oxazolidinone antibacterial drug, and its therapeutic drug monitoring and individualized treatment have been challenged since its approval
We aimed to evaluate the tolerability and efficacy of linezolid in children for treating suspected and diagnosed Gram-positive bacterial infections
aureus
Linezolid is the first representative of a new class of synthetic antibacterial agents, the oxazolidinones
0%) improved; treatment failure and non-evaluable outcomes were